Bailong Chuangyuan(SH:605016) Xinda Securities·2026-01-25 08:06Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company achieved record high performance in 2025, with revenue reaching 1.379 billion yuan, a year-on-year increase of 19.75%, and a net profit attributable to shareholders of 366 million yuan, up 48.94% year-on-year [1][3] - The growth was driven by product structure optimization, cost reduction through technological advancements, and increased capacity utilization [3] - The launch of new products, particularly D-alloheptulose, is expected to boost sales in the food and beverage market [3] - Ongoing capacity expansion projects are set to enhance production capabilities and support future growth [3] Financial Summary - Total revenue for 2025 is projected at 1.379 billion yuan, with a growth rate of 19.7% for 2025 and expected to reach 2.260 billion yuan by 2027 [4] - Net profit attributable to shareholders is forecasted to grow from 366 million yuan in 2025 to 611 million yuan in 2027, reflecting a compound annual growth rate of 31.3% [4] - The gross margin is expected to improve to 42.3% in 2025, with a projected EPS of 0.87 yuan for 2025, increasing to 1.45 yuan by 2027 [4]